Risk for at least one adverse event per patient · patients with depression and dementia
Antidepressant treatment probably leads to higher number of patients experiencing at least one adverse event compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Postnatal depression (17 weeks) · women with a history of postnatal depression
It is very uncertain whether the intervention changes postnatal depression (17 weeks) (very low certainty).
1 finding from 1 review
Intervention not reported
Overall maternal satisfaction (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improvement in the maternal relationship with the baby (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Establishment or continuation of breastfeeding (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects experienced by mother and/or foetus or nursing baby · women with a history of postnatal depression
1 finding from 1 review
Intervention not reported
Acceptability of treatment (17 weeks) · women with a history of postnatal depression
1 finding from 1 review
Intervention not reported
Overall maternal satisfaction (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improvement in the maternal relationship with the baby (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Establishment or continuation of breastfeeding (17 weeks) · women with a history of postnatal depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Postnatal depression (17 weeks) · women with a history of postnatal depression
It is very uncertain whether the intervention changes postnatal depression (17 weeks) (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects experienced by mother and/or fetus or nursing baby · women with a history of postnatal depression
1 finding from 1 review
Intervention not reported
Acceptability of treatment (17 weeks) · women with a history of postnatal depression
1 finding from 1 review
Improvement in depression at 6‐12 weeks: HAM‐D score (continuous) · adults living with HIV and depression
1 finding from 1 review
Dropout · adults living with HIV and depression
It is very uncertain whether selective serotonin reuptake inhibitors (SSRI) changes study dropouts at 6‐12 weeks compared with tricyclic antidepressant (TCA) (very low certainty).
1 finding from 1 review
Adverse effects during antidepressant treatment period (0‐12 weeks) · adults living with HIV and depression
It is very uncertain whether selective serotonin reuptake inhibitors (SSRI) changes adverse effects during antidepressant treatment period (0‐12 weeks) compared with tricyclic antidepressant (TCA) (very low certainty).
1 finding from 1 review
Improvement in depression at 6‐12 weeks: HAM‐D score (continuous) · adults living with HIV and depression
1 finding from 1 review
Improvement in depression at 6‐12 weeks: HAM‐D score (dichotomized) · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in improvement in depression at 6‐12 weeks: HAM‐D score (dichotomized) compared with atypical agent (low certainty).
1 finding from 1 review
Improvement in depression at 6‐12 weeks: CGI‐I (score of 1 or 2) · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in improvement in depression at 6‐12 weeks: CGI‐I (score of 1 or 2) compared with atypical agent (low certainty).
1 finding from 1 review
Dropout · adults living with HIV and depression
Selective serotonin reuptake inhibitor (SSRI) showed no clear difference in study dropouts at 6‐12 weeks compared with atypical agent (low certainty).
1 finding from 1 review